Growing community of inventors

Brussels, Belgium

Jean Herman

Average Co-Inventor Count = 4.44

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Jean HermanThierry R Boon-Falleur (4 patents)Jean HermanPierre Van Der Bruggen (4 patents)Jean HermanPierre G Coulie (4 patents)Jean HermanImmanuel Luescher (2 patents)Jean HermanJean Herman (4 patents)Thierry R Boon-FalleurThierry R Boon-Falleur (143 patents)Pierre Van Der BruggenPierre Van Der Bruggen (73 patents)Pierre G CouliePierre G Coulie (53 patents)Immanuel LuescherImmanuel Luescher (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ludwig Institute for Cancer Research Limited (3 from 525 patents)

2. Ludwig Institute of Cancer Research (1 from 3 patents)


4 patents:

1. 6171806 - Isolated peptide defined by SEQ ID NO: 17 and uses thereof

2. 6060257 - Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof

3. 5977300 - Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof

4. 5744353 - Cytolytic T cell lines which bind to complexes of tumor rejection

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…